The coolest place on the internet, according to this tagline.
AskArchiveFAQ

October 27, 2013
23:11 // 9 months ago
December 8, 2012

FDA panel votes against recommending Zohydro for approval

  • 11 - 2FDA advisory committee vote against recommending a new high-strength painkiller, Zohydro, for approval in March. The drug consists of hydrocodone bitartrate, which regulators fear could become a popular alternative for addicts of opiate painkillers — painkiller abuse accounts for 75% of overdose deaths in the United States. Conversely, the drug’s effect might indeed help some people — it’s intended to provide constant, slow-release relief to those in constant pain, without the use of acetaminophen, which can lead to liver damage with overuse. source
16:45 // 1 year ago
December 27, 2011
Zohydro, a super-powered (and addictive) painkiller?
High-strength painkiller sparks addiction concerns: A new prescription painkiller currently in development has stoked fears among addiction experts, due to its high concentration of a substance already known to be hyper-addictive. Zohydro, a new medication for which pharmaceutical company Zogenix plans to apply for FDA approval to sell sometime early next year, contains ten times the amount of hydrocodone as Vicodin does — one of the most abused drugs in the United States. Said April Rovero, of the National Coalition Against Prescription Drug Abuse: “I have a big concern that this could be the next OxyContin. We just don’t need this on the market.” (photo by The Javorac on Flickr) source
Follow ShortFormBlog

High-strength painkiller sparks addiction concerns: A new prescription painkiller currently in development has stoked fears among addiction experts, due to its high concentration of a substance already known to be hyper-addictive. Zohydro, a new medication for which pharmaceutical company Zogenix plans to apply for FDA approval to sell sometime early next year, contains ten times the amount of hydrocodone as Vicodin does — one of the most abused drugs in the United States. Said April Rovero, of the National Coalition Against Prescription Drug Abuse: “I have a big concern that this could be the next OxyContin. We just don’t need this on the market.” (photo by The Javorac on Flickr) source

Follow ShortFormBlog

15:53 // 2 years ago